ST. PETERSBURG, FL–(Marketwired – May 1, 2017) – Consilium Global Research (CGR), an investor recognition company that connects companies and investors, today announced that it issued an Executive Summary on Chinese Investors.com, Inc. (OTCQB: CIIX).
The 4 page Executive Summary has several segments: company overview, key highlights, benefits of CBD Oil, industry analysis, Comparable analysis, financial highlights, SWOT analysis and updates.
About Chinese Investors.com, Inc.
ChineseInvestors.com (OTCQB: CIIX) is undergoing a huge transformation. CIIX was founded in 1999 (went public in January 2012) and is headquartered in San Gabriel, CA. Traditionally the company has offered a range of consulting services, information products and web-based tools for investor education, including real time market commentary, analysis and education to the Chinese investor via the company’s website, www.chinesefn.com.
By the end of 2016, CIIX begun implementing its plans for a new website, mobile application and online distribution of CBD oils for the booming global Medical Marijuana industry. Recently CIIX launched the first CBD health products online store in the Chinese language and established and registered XiBiDi Biotechnology Co., LTD., in the Pudong free-trade area in Shanghai, providing an opportunity to reach a customer base of 1.4 billion people. XiBiDi Technology will focus on the online/offline sales of health products, including hemp-derived CBD, as well as hemp-based food and beverages. XiBiDi technology will also be the operation of CIIX’s recently launched online store, www.chineseCBDoil.com, which will primarily focus on selling, where-legal, hemp-based CBD nutrient and health products to Chinese speaking customers worldwide, through the online retail process.
CIIX also launched the world’s first Chinese-language mobile cannabis navigation app. This app has already been approved for download by the Apple store.
CIIX is also in preparations to open a retail store based in the predominantly Chinese community of San Gabriel, CA. In addition to retail and direct sales, the company will focus on the legal import of hemp-based (but not CBD oil products) health products in China and the export of hemp food and beverages to the United States, Canada and Europe.
CIIX will continue to focus on investment on both the R&D and distribution of CBD medicine and health products. CIIX’s mission is to become the leading Chinese Medicine Marijuana publicly traded company.
About Stock Market Manager
Stock Market Manager provides distribution of press releases, research and corporate news to its proprietary database of investors and financial professionals as well as financial terminals, print, broadcast and trade media, wire services, news agencies, databases, portals and websites.
About Consilium Global Research
Consilium Global Research (CGR) is an Investor Recognition Company that provides Research and Strategic Advisory Services to help public companies raise their profile in the investment community. The CGR business model is built upon three mutually – reinforced pillars.
- Strategic Advisory – identifies problems and delivers custom solutions.
- Insightful Wall Street Research Coverage – Research that formulates an equity story that will resonate with the investment community (institutional and retail).
- A Corporate Access Program – meeting with key decision makers at major institutions and high net worth retail groups.
The CGR Business Plan is executed by a highly respected professional team known for their integrity and results oriented approach. The end result is a broader investor base (institutional and retail), increased trading activity and subsequently lower cost of capital.
Consilium Global Research bridges the gap between public companies and the investment community.
For more information, visit www.ConsiliumGlobalResearch.com
Forward Looking Statements
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that are intended to be covered by the safe harbor created by such sections. Such statements are based on good faith assumptions that ChineseInvestors.com, Inc. believes are reasonable but which are subject to a wide range of uncertainties and business risks that could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements.
Such factors include, among others, the risk that anticipated production levels are not attained, the risk that the mine plan changes due to rising costs or other operational details, the risk that the Company is unable to obtain sufficient funds necessary to continue operations, as well as other uncertainties and risk factors. Actual results, developments and timetables could vary significantly from the estimates presented. Readers are cautioned not to put undue reliance on forward-looking statements. CIIX disclaims any intent or obligation to update publicly such forward-looking statements, whether as a result of new information, future events or otherwise.
Consilium Global Research